Blue Jet Healthcare Limited
ICICI Prudential Mutual Fund increased its stake in Blue Jet Healthcare from 1.19% to 3.83%, raising its shareholding from 20,71,816 to 72,55,905 shares. This increase includes participation in a Qualified Institutional Placement (QIP) where various ICICI Prudential schemes, including ICICI Prudential Value Fund and ICICI Prudential Manufacturing Fund, collectively purchased a significant number of shares at ₹506 apiece.
A pharmaceutical and healthcare ingredients manufacturer, Blue Jet Healthcare produces saccharin, its salts, and other chemical intermediates for the pharmaceutical and food industries. Established in 1968 as Jet Chemicals, it was India's first manufacturer of saccharin and artificial sweeteners. The company supplies specialized active ingredients and intermediates to domestic pharmaceutical manufacturers and industrial clients across various sectors.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.